A4STUDY.ORG: Keyword Density Checker

Total words: 2520 | 2-word phrases: 666 | 3-word phrases: 728 | 4-word phrases: 746

PAGE INFO

Title	Try to keep the title under 60 characters (35 characters) Alzheimer's Studies and Trials
Description	Try to keep the meta description between 50 - 160 characters (352 characters) The landmark Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study (A4 Study) enrolled 1,169 healthy older adults with normal memory but who might be at risk for Alzheimer’s due to family history of the disease and elevated levels of amyloid plaque in the brain. The primary study aims are to prevent the memory loss associated with the disease.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (8 characters) A4 Study

ONE WORD PHRASES 380 Words

#	Keyword	Frequency	Density
1	the	51	13.42%
2	and	25	6.58%
3	of	23	6.05%
4	study	22	5.79%
5	a4	19	5.00%
6	to	17	4.47%
7	for	14	3.68%
8	in	10	2.63%
9	a	9	2.37%
10	with	8	2.11%

TWO WORD PHRASES 666 Words

#	Keyword	Frequency	Density
1	a4 study	10	1.50%
2	the a4	9	1.35%
3	of a	7	1.05%
4	in the	6	0.90%
5	on the	5	0.75%
6	alzheimer’s disease	4	0.60%
7	the study	4	0.60%
8	as of	4	0.60%
9	of the	3	0.45%
10	clinical trial	3	0.45%
11	4 and	3	0.45%
12	the brain	3	0.45%
13	study team	3	0.45%
14	national institute	3	0.45%
15	for the	3	0.45%
16	the national	3	0.45%
17	foundation an	2	0.30%
18	alzheimer’s the	2	0.30%
19	the list	2	0.30%
20	study leadership	2	0.30%

THREE WORD PHRASES 728 Words

#	Keyword	Frequency	Density
1	the a4 study	5	0.69%
2	in the brain	3	0.41%
3	the national institute	3	0.41%
4	alzheimers therapeutic research	2	0.27%
5	a4 study solanezumab	2	0.27%
6	release a4 study	2	0.27%
7	press release a4	2	0.27%
8	study team lists	2	0.27%
9	institutes of health	2	0.27%
10	national institutes of	2	0.27%
11	study leadership teams	2	0.27%
12	therapeutic research institute	2	0.27%
13	solanezumab results march	2	0.27%
14	of august 2018	2	0.27%
15	as of august	2	0.27%
16	screening as of	2	0.27%
17	– journal version	2	0.27%
18	of may 2023	2	0.27%
19	as of may	2	0.27%
20	longitudinal as of	2	0.27%
21	the a4 and	2	0.27%
22	a4 and learn	2	0.27%
23	study solanezumab results	2	0.27%
24	the national institutes	2	0.27%
25	research institute logo	2	0.27%
26	data from the	1	0.14%
27	infusions and a	1	0.14%
28	weeks over 4	1	0.14%
29	over 4 and	1	0.14%
30	4 and half	1	0.14%

FOUR WORD PHRASES 746 Words

#	Keyword	Frequency	Density
1	alzheimers therapeutic research institute	2	0.27%
2	therapeutic research institute logo	2	0.27%
3	screening as of august	2	0.27%
4	as of august 2018	2	0.27%
5	press release a4 study	2	0.27%
6	release a4 study solanezumab	2	0.27%
7	a4 study solanezumab results	2	0.27%
8	study solanezumab results march	2	0.27%
9	national institutes of health	2	0.27%
10	the national institutes of	2	0.27%
11	longitudinal as of may	2	0.27%
12	as of may 2023	2	0.27%
13	the a4 and learn	2	0.27%
14	screening pet still clinically	1	0.13%
15	of elevated amyloid plaque	1	0.13%
16	for 240 weeks over	1	0.13%
17	month for 240 weeks	1	0.13%
18	a month for 240	1	0.13%
19	85 years of age	1	0.13%
20	years of age with	1	0.13%
21	once a month for	1	0.13%
22	sites once a month	1	0.13%
23	clinical sites once a	1	0.13%
24	were coming to the	1	0.13%
25	participants were coming to	1	0.13%
26	evidence of elevated amyloid	1	0.13%
27	amyloid plaque accumulation in	1	0.13%
28	elevated amyloid plaque accumulation	1	0.13%
29	pet still clinically normal	1	0.13%
30	period participants were coming	1	0.13%
31	placebocontrolled period participants were	1	0.13%
32	the placebocontrolled period participants	1	0.13%
33	plaque accumulation in the	1	0.13%
34	accumulation in the brain	1	0.13%
35	in the brain on	1	0.13%
36	at high risk for	1	0.13%
37	but at high risk	1	0.13%
38	normal but at high	1	0.13%
39	clinically normal but at	1	0.13%
40	still clinically normal but	1	0.13%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://atri.usc.edu/about/	Whois	usc.edu
2	https://atri.usc.edu/timeline/	Whois	usc.edu
3	https://usccareers.usc.edu/location/san-diego-jobs/1728-1209/6252001-5332921-5391811/4	Whois	usc.edu
4	https://atri.usc.edu/groups/	Whois	usc.edu
5	https://atri.usc.edu/groups/	Whois	usc.edu
6	https://atri.usc.edu/ntrd/	Whois	usc.edu
7	https://atri.usc.edu/participate/	Whois	usc.edu
8	https://atri.usc.edu/student-summer-research-program/	Whois	usc.edu
9	https://atri.usc.edu/our-people/	Whois	usc.edu
10	https://atrinews.usc.edu/	Whois	usc.edu
11	https://atrinews.usc.edu/resources	Whois	usc.edu
12	https://atri.usc.edu/contact-donate/	Whois	usc.edu
13	https://www.actcinfo.org/wp-content/uploads/2024/07/A4-LEARN_Acknowledgements-Longitudinal-List-Final-for-Website.pdf	Whois	actcinfo.org
14	https://www.actcinfo.org/wp-content/uploads/2024/07/A4-LEARN-Study-Team-List-Longitudinal-as-of-May-2023-Journal-Version-1.pdf	Whois	actcinfo.org
15	https://www.actcinfo.org/wp-content/uploads/2024/07/A4-Acknowledgements.pdf	Whois	actcinfo.org
16	https://www.actcinfo.org/wp-content/uploads/2024/07/A4-Acknowledgements-Journal-Format.pdf	Whois	actcinfo.org
17	https://atri.usc.edu/wp-content/uploads/2022/12/Brigham-Womens-Press-Release-A4-Study-Solanezumab-Results-March-2023.pdf	Whois	usc.edu
18	https://atri.usc.edu/wp-content/uploads/2022/12/Eli-Lilly-Press-Release-A4-Study-Solanezumab-Results-March-2023.pdf	Whois	usc.edu
19	https://atri.usc.edu/wp-content/uploads/2022/12/Selected-Slides-Study-Results-A4-Study-Alzheimer-Association-International-Conference-July-2023-1.pdf	Whois	usc.edu
20	https://www.a4studydata.org/	Whois	a4studydata.org
21	https://atri.usc.edu/contact/	Whois	usc.edu
22	https://atri.usc.edu/take-action/	Whois	usc.edu
23	https://usccareers.usc.edu/location/san-diego-jobs/1728-1209/6252001-5332921-5391811/4	Whois	usc.edu
24	https://impact-ad.org/	Whois	impact-ad.org
25	https://atri.usc.edu/contact-donate/	Whois	usc.edu
26	https://accessibility.usc.edu/accessibility-at-usc/digital-accessibility/	Whois	usc.edu